Caesars Entertainment (CZR) said early Thursday its Caesars Entertainment Operating unit filed an amended reorganization plan to convert the unit into a real estate investment trust in a U.S. bankruptcy court. Caesar’s operating subsidiary said the restructuring plan is supported by holders of more than 80% of its first lienRead More

Morningstar is raising the red flag over Micron Technology, Inc. (NASDAQ:MU), issuing a very high uncertainly rating on the stock. In updated comment, Morningstar has predicated its views on Micron’s 4Q2015 results and what is happening in the DRAM market. According to Morningstar, the results that Micron reported for 4QRead More

Esterline (ESL) shares slumped to a fresh two-year low Friday morning after the specialty manufacturer serving the global aerospace and defense markets, reported an unexpected drop in fiscal third-quarter profit and revenue, and cut its guidance on full-year results. After the close on Thursday, the company reported that GAAP earningsRead More

Actavis (ACT) said Friday a phase 3 study comparing dosage of its Dalvance for the treatment of acute bacterial skin and skin structure infections that are caused by susceptible Gram-positive bacteria reached both its primary and secondary endpoints. Preliminary data showed a single dose of 1500 mg Dalvance achieved itsRead More

Aspen Insurance (AHL), a Bermuda-based insurance company, reported Wednesday morning it will distribute a quarterly dividend of $0.21 per share, up 5% or a penny from the previous quarter. The dividend is payable on May 27 to holders of record on May 8. AHL edged lower in recent morning trade,Read More

Sage Therapeutics, Inc. (NASDAQ:SAGE), a clinical-stage biopharmaceutical company, said Tuesday it has closed its underwritten public offering of 2.6 million shares of common stock, including over-allotments, at a public offering price of $52.50 per share, or for gross proceeds of approximately $138 million. Sage Therapeutics, Inc. (NASDAQ:SAGE) shares opened theRead More